| Attributes | Values |
|---|
| rdf:type
| |
| description
| - videnskabelig artikel (da)
- article científic (ca)
- article scientific (oc)
- articol științific (ro)
- articolo scientifico (it)
- artigo científico (gl)
- artigo científico (pt)
- artigo científico (pt-br)
- artikull shkencor (sq)
- artikulong pang-agham (tl)
- artykuł naukowy (pl)
- artículo científico (es)
- bilimsel makale (tr)
- scienca artikolo (eo)
- teaduslik artikkel (et)
- tieteellinen artikkeli (fi)
- tudományos cikk (hu)
- vedecký článok (sk)
- vetenskaplig artikel (sv)
- vitenskapelig artikkel (nb)
- vitskapeleg artikkel (nn)
- vědecký článek (cs)
- wetenschappelijk artikel (nl)
- wissenschaftlicher Artikel (de)
- επιστημονικό άρθρο (el)
- научна статия (bg)
- научная статья (ru)
- научни чланак (sr)
- מאמר מדעי (he)
- სამეცნიერო სტატია (ka)
- บทความทางวิทยาศาสตร์ (th)
- artikel ilmiah (id)
- bài báo khoa học (vi)
- naučni članak (sr-el)
- мақолаи илмӣ (tg-cyrl)
- научни чланак (sr-ec)
- article scientifique (fr)
- বৈজ্ঞানিক নিবন্ধ (bn)
- 2016 nî lūn-bûn (nan)
- 2016年の論文 (ja)
- 2016年論文 (zh-hk)
- 2016年論文 (zh-tw)
- 2016年論文 (zh-hant)
- 2016年論文 (yue)
- 2016年論文 (zh-mo)
- 2016年论文 (zh)
- 2016年论文 (zh-cn)
- 2016年论文 (zh-sg)
- 2016年论文 (zh-hans)
- 2016年论文 (wuu)
- 2016年论文 (zh-my)
- 2016년 논문 (ko)
- artículu científicu espublizáu en 2016 (ast)
- наукова стаття, опублікована в травні 2016 (uk)
- مقالة علمية نشرت في 24 مايو 2016 (ar)
- scientific article published on 24 May 2016 (en)
- scientific article published on 24 May 2016 (en-ca)
- scientific article published on 24 May 2016 (en-gb)
|
| publication date
| |
| publication date
| |
| cites work
| |
| cites work
| - BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth
- Combined oral contraceptives in women with systemic lupus erythematosus
- A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
- A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group
- Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
- B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations.
- Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE.
- Efficacy and safety of subcutaneous tabalumab in patients with systemic lupus erythematosus: results from ILLUMINATE-1, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study
- Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controll
|
| author name string
| |
| author name string
| - B H Rovin
- J Radhakrishnan
- T D Forrester
- P W Anderson
|
| rdfs:label
| - The impact of tabalumab on the kidney in systemic lupus erythematosus: results from two phase 3 randomized, clinical trials (en)
- The impact of tabalumab on the kidney in systemic lupus erythematosus: results from two phase 3 randomized, clinical trials (nl)
- The impact of tabalumab on the kidney in systemic lupus erythematosus: results from two phase 3 randomized, clinical trials (ast)
|
| skos:prefLabel
| - The impact of tabalumab on the kidney in systemic lupus erythematosus: results from two phase 3 randomized, clinical trials (en)
- The impact of tabalumab on the kidney in systemic lupus erythematosus: results from two phase 3 randomized, clinical trials (nl)
- The impact of tabalumab on the kidney in systemic lupus erythematosus: results from two phase 3 randomized, clinical trials (ast)
|
| name
| - The impact of tabalumab on the kidney in systemic lupus erythematosus: results from two phase 3 randomized, clinical trials (en)
- The impact of tabalumab on the kidney in systemic lupus erythematosus: results from two phase 3 randomized, clinical trials (nl)
- The impact of tabalumab on the kidney in systemic lupus erythematosus: results from two phase 3 randomized, clinical trials (ast)
|
| author
| |
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)